基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Arrow Alexander K., 首席财务官. Insider active across 1 company, notably Protagenic Therapeutics, Inc.\new. In total, 3 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €24k. History available since 29 April 2021. The latest transaction was filed on 12 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Arrow Alexander K. is the Chief Financial Officer at Protagenic Therapeutics, Inc. In this role, he oversees the company's financial operations and is involved in strategic decision-making. His expertise in finance allows him to effectively manage financial resources and optimize the company's performance. He collaborates with other executives to ensure growth and profitability.